TrialCancer immunology, immunotherapy : CII2019

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Bas D Koster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.